Skip to content
OpenCapital
Get started

AngioDynamics ANGO Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%
TFX
TeleflexTFX
$7.74B-2.0%
Stryker logo
StrykerSYK
$137.35B-12.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%
ICU Medical logo
ICU MedicalICUI
$4.26B-10.6%

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%—

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0×0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

$471.5Mmarket cap+$7.9Mtotal debt−$37.8Mcash and equivalents=$441.62M

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's enterprise value?
AngioDynamics (ANGO) reported enterprise value of $441.62M in Q4 2025.
How has AngioDynamics's enterprise value changed year-over-year?
AngioDynamics's enterprise value increased by 30.5% year-over-year, from $338.34M to $441.62M.
What is the long-term trend for AngioDynamics's enterprise value?
Over 4 years (2021 to 2025), AngioDynamics's enterprise value has grown at a -20.1% compound annual growth rate (CAGR), from $855.17M to $348.55M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.